Login / Signup

Novel Therapies for Hepatocellular Carcinoma.

Lorenza Rimassa
Published in: Cancers (2020)
Since 2007, for patients with advanced- or intermediate-stage hepatocellular carcinoma (HCC) unsuitable for locoregional treatments and with preserved liver function, the multikinase inhibitor (MKI) sorafenib has been the worldwide standard of care [...].
Keyphrases
  • healthcare
  • palliative care
  • quality improvement
  • affordable care act
  • pain management
  • chronic pain